**Section 2**

**Physical Factors** 

10 Oxidative Stress – Environmental Induction and Dietary Antioxidants

Ozimek, P.; Veenhuis, M. & van der Klei, I. (2005). Alcohol oxidase: a complex peroxisomal, oligomeric flavoprotein. *FEMS Yeast Research*, Vol.5, No.11, pp. 975-983. Sies, H. (1985). Oxidative stress: Introductory remarks. In: *Oxidative stress*, Sies H, (Ed.), pp.

Shin, A.; Oh, C. , & Park, J. (2006). Glycation-induced inactivation of antioxidant enzymes

Sirker, A.; Zhang, M. & Shah. A. (2011). NADPH oxidases in cardiovascular disease: insights

Vazquez-Torres, A.; Stevanin, T.; Jones-Carson, J.; Castor, M.; Read, R. & Fang, F. (2008).

Wedgwood, S.; Lakshminrusimha, S.; Fukai, T.; Russell, J.; Schumacker, P. & Steinhorn, R.

Yang, L.; Latchoumycandane, C.; McMullen, M.; Pratt, B.; Zhang, R.; Papouchado. B.; Nagy,

and modulation of cellular redox status in lens cells. *Archives of Pharmacal Research*,

from *in vivo* models and clinical studies. *Basic Research in Cardiology*, Vol.106, No.5,

Analysis of nitric oxide-dependent antimicrobial actions in macrophages and mice.

(2011). Hydrogen peroxide regulates extracellular superoxide dismutase activity and expression in neonatal pulmonary hypertension. *Antioxidants and Redox* 

L.; Feldstein, A. & McIntyre, T. (2010). Chronic alcohol exposure increases circulating bioactive oxidized phospholipids. *Journal of Biological Chemistry*, Vol.285,

1-8, Academic Press, London.

*Methods in Enzymology*, Vol.437, pp. 521-538.

*Signaling*, Vol.15, No.6, pp. 1497-1506.

Vol.29, No.7, pp. 577-581.

No.29, pp. 22211-22220.

pp. 735-747.

**2** 

**Oxidative Stress Induced Damage of the** 

**Human Retina: Overview of Mechanisms** 

A number of studies have shown that excessive visible light or a special wavelength (blue light) can induce damage to photoreceptor and retinal pigment epithelial cells of the retina, inducing apoptosis. Most of these studies were performed in experimental animal models. However, the mechanisms which lead to damage and subsequently to degenerative diseases like age related macular degeneration (ARMD) remain still unclear. Whether direct interaction of light with retinal cells or a secondary mechanism of transport or circulation of the retinal pigment epithelium or the choroid causes this retinal damage is currently under debate. Cellular mechanisms involved are lipid peroxidation, production of reactive oxygen species (ROS), apoptosis, DNA-damage and others. Clinical or epidemiological studies on this topic are rare and publications about light damage of retinal cells *in vivo* are difficult to achieve. Nevertheless, the clinical practise to implant yellow artificial lenses during cataract surgery is a common practise. These implants are expected to prevent blue light damage to the aging retina. We will address the fact that numerous basic scientific publications point to a rationale for this practice, although it is often difficult to derive clear-cut evidence from clinical epidemiological studies for the preventive use of yellow tinted artificial lenses. We refer to studies showing that the shortwave part of the visible spectrum of light can be harmful to the retina, especially to the macula and optic nerve. For this, we have screened the literature for the major sources of radical production and for the targets of oxidative stress after impingement of "blue light" on the retina. Furthermore, we can show that many studies in cell and molecular biology, animal experiments and first clinical trials point to a preferential use of yellow tinted lenses especially in the elderly and ARMD patients. As in several other fields, so too in this field does "cell biological knowledge" exceed clinical knowledge. Thus, prevention strategies and therapies are still missing. It is important that clinicians should become more aware of this topic so that more informed treatments

**1. Introduction** 

decisions can be made.

**and Preventional Strategies** 

*2Institut für Anatomie, Medizinische Fakultät der TU Dresden,* 

*3CRTD, Zentrum für Regenerative Therapien Dresden, DFG-Forschungszentrum und Exzellenzcluster, TU Dresden,* 

Klio Ai Becker1 and Richard Funk2,3 *1Augenklinik, Klinikum Chemnitz gGmbH,* 

Katrin Engelmann1,2,3,

*Germany* 
